EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C13H10N2O4 |
| Net Charge | 0 |
| Average Mass | 258.233 |
| Monoisotopic Mass | 258.06406 |
| SMILES | O=C1CC[C@@H](N2C(=O)c3ccccc3C2=O)C(=O)N1 |
| InChI | InChI=1S/C13H10N2O4/c16-10-6-5-9(11(17)14-10)15-12(18)7-3-1-2-4-8(7)13(15)19/h1-4,9H,5-6H2,(H,14,16,17)/t9-/m1/s1 |
| InChIKey | UEJJHQNACJXSKW-SECBINFHSA-N |
| Roles Classification |
|---|
| Application: | sedative A central nervous system depressant used to induce drowsiness or sleep or to reduce psychological excitement or anxiety. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| (R)-thalidomide (CHEBI:61917) has role sedative (CHEBI:35717) |
| (R)-thalidomide (CHEBI:61917) is a 2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione (CHEBI:74947) |
| (R)-thalidomide (CHEBI:61917) is enantiomer of (S)-thalidomide (CHEBI:61918) |
| Incoming Relation(s) |
| thalidomide (CHEBI:9513) has part (R)-thalidomide (CHEBI:61917) |
| (S)-thalidomide (CHEBI:61918) is enantiomer of (R)-thalidomide (CHEBI:61917) |
| IUPAC Name |
|---|
| 2-[(3R)-2,6-dioxopiperidin-3-yl]-1H-isoindole-1,3(2H)-dione |
| Synonyms | Source |
|---|---|
| (+)-thalidomide | ChemIDplus |
| R-(+)-thalidomide | ChemIDplus |
| (R)-(+)-thalidomide | ChEBI |
| d-thalidomide | ChemIDplus |
| D-thalidomide | ChemIDplus |
| Registry Numbers | Sources |
|---|---|
| Reaxys:5756815 | Reaxys |
| CAS:2614-06-4 | ChemIDplus |